Skip to main content

American Diabetes Association affordability resources

Current guidance on insulin access and diabetes cost assistance, organised by insurance situation.

Best for

Anyone working out which insulin or supply assistance applies to their specific coverage.

Why Kave includes this

Insulin assistance rules differ sharply depending on whether you have commercial insurance, Medicare, Medicaid, or nothing, and most guidance ignores that distinction. Organising the answer by coverage situation is what makes it usable, and the ADA keeps it current as manufacturer programs change.

Limitations Kave wants you to know about

  • Information and referral, not a direct assistance program.
  • Manufacturer program terms change; confirm on the manufacturer's own page.

Verification

Compiled by Kave on July 1, 2026 and link-checked. Not yet independently verified. Kave assembled this from the organisation’s own published material and confirmed the links resolve. No reviewer has confirmed the eligibility details against the source, so check them on the official site before you rely on them.

Compiled
July 1, 2026 (28 days ago)
Next scheduled review
September 29, 2026
Reviewed by
Not yet reviewed

Sources used

Kave quality score

85/100

Kave lists resources scoring 80 or above that also clear all four mandatory gates.

  • Patient impact19.5/25
  • Affordability or financial value18.4/20
  • Accessibility12.6/15
  • Transparency12.6/15
  • Ease of use8/10
  • Geographic reach4.7/5
  • Institutional credibility4.6/5
  • Privacy and data practices4.1/5

Geographic reach is deliberately worth only five points, so a strong local resource is not pushed out by a weak national one. Read the methodology.

American Diabetes Association affordability resources | Kave Health